Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

Lior mor

609 POSTS

Exclusive articles:

SKN | Standard Nuclear Prices Downsized IPO at $15, Raising $150 Million to Expand Advanced Nuclear Fuel Production

Standard Nuclear has successfully completed its initial public offering after reducing both the size and pricing of the deal. The company raised $150 million...

SKN | AMR Resources Acquisition Corp. Targets Market Debut With SPAC IPO Amid Renewed Investor Interest

AMR Resources Acquisition Corp. is preparing for its initial public offering, seeking to capitalize on improving sentiment in the IPO and special purpose acquisition...

SKN | Phalanx Acquisition I Files for $175 Million IPO to Pursue Financial Services and Fintech Deals

Phalanx Acquisition I has filed for an initial public offering (IPO) seeking to raise up to $175 million as it looks to capitalize on...

SKN | Csquare Prices $1.1 Billion IPO Below Proposed Range as Data Center Demand Remains Robust

Data center operator Csquare has priced its initial public offering (IPO) at $21 per share, below its previously marketed range of $23 to $27,...

SKN | Csquare Targets IPO to Accelerate Enterprise Software Growth and Expand Market Presence

Csquare, Inc. is preparing for its anticipated IPO as the enterprise technology company seeks to raise fresh capital to support product innovation, customer acquisition,...

Breaking

SKN | Viking Acquisition Corp. II Advances SPAC IPO Plans as Investors Evaluate New Market Opportunities

Viking Acquisition Corp. II is preparing for its public...

SKN | Goldgroup Mining Inc. Positions for Public Market Growth as Investors Monitor Mining Sector Opportunities

Goldgroup Mining Inc. is attracting attention from investors as...

SKN | Oruka Therapeutics Extends Rally as Investors Bet on Autoimmune Pipeline Ahead of August Catalyst

Oruka Therapeutics (NASDAQ: ORKA) closed at $92.70, gaining $9.66...

SKN | Dianthus Therapeutics (DNTH) Stock Climbs Over 10% as Investors Continue to Back Autoimmune Disease Pipeline

Dianthus Therapeutics (NASDAQ: DNTH) posted another strong trading session,...
spot_imgspot_img